An integrated tool for determining the primary origin site of metastatic tumours

AIMS: Cancers of unknown primary sites account for 3%–5% of all malignant neoplasms. Current diagnostic workflows based on immunohistochemistry and imaging tests have low accuracy and are highly subjective. We aim to develop and validate a gene-expression classifier to identify potential primary sit...

Descripción completa

Detalles Bibliográficos
Autores principales: dos Santos, Marcos Tadeu, de Souza, Bruno Feres, Cárcano, Flavio Mavignier, Vidal, Ramon de Oliveira, Scapulatempo-Neto, Cristovam, Viana, Cristiano Ribeiro, Carvalho, Andre Lopes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204949/
https://www.ncbi.nlm.nih.gov/pubmed/29248889
http://dx.doi.org/10.1136/jclinpath-2017-204887

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6204949/
https://www.ncbi.nlm.nih.gov/pubmed/29248889
http://dx.doi.org/10.1136/jclinpath-2017-204887

Ejemplares similares